SERTAD2 and pancreatic adenocarcinoma: All of the 4 ARGs in the formula, including CALB2, NLGN2, NCAPG, SERTAD2, are identified with significant prognostic value in overall survival time of TCGA-PAAD patients (Figure 5I–5L).